Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2018

 With reference to the captioned subject, we enclose herewith Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 30th September, 2018, issued by M/s. Samdani Shah & Kabra, Practising Company Secretaries, Vadodara. We request you to kindly take the same on record.
10-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0880 Name of the Signatory :- Charandeep Singh SalujaDesignation :- Company Secretary and Compliance Officer
10-10-2018
Bigul

Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the captioned subject, we hereby confirm that all activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent viz. Link Intime India Private Limited, which is a SEBI approved Category-I Registrar & Transfer Agent, registered with the Securities and Exchange Board of India (SEBI Registration Number : INR000004058). We request you to kindly take the same on record.
10-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the shareholder(s) and / or legal heir(s) of the registered shareholder(s) in English language newspaper - Business Standard on 9th October, 2018.
09-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 9th October, 2018 in Economic Times English and Gujarati Edition. We request you to kindly take the same on record.
09-10-2018
Bigul

Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2018

 ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2018 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Monday, 22nd October, 2018, inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2018....
08-10-2018
Bigul

Compliance Report On The Implementation Of BSE Limited (BSE) Circular No. LIST/COMP/15/2018-19 Dated 5Th July, 2018.

 The Company has complied with the provisions of the referred Circular by inter alia taking the following steps: 1.The Company through its Registrar and Transfer Agent, Link Intime India Private Limited (RTA), has sent a letter and followed it up with a reminder, both dispatched through Speed post, to the Shareholders holding physical certificates, appraising them about the amendment in Regulation 40 of the SEBI (Listing Obligations and Disclosure...
03-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Desvenlafaxine Extended-Release Tablets, 25 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
17-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of proposed transferee claiming shares from the Company's Unclaimed Suspense Account in English language newspaper - Business Standard on 14th September, 2018. We request you to kindly take the same on record.
14-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
14-09-2018
Next Page
Close

Let's Open Free Demat Account